genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Primers
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Drug Discovery
SARS-CoV-2 Docking Portal Downregulated by Existing Liver Drug
Genomics
Viral Infection Blocked by Inhibiting Enzyme Involved in Kidney Filtration
Neurological Disorders
Misfolding Protein May Pave the Road to Personalized Medicine Approach
Gastrointestinal Disorders
Inflammatory Bowel Disease Healing Hindered by Immune Cells
Coronavirus
Omicron’s Origins: How the SARS-CoV-2 Variant Emerged in Africa
Insights
All
Trends for 2020
Trends for 2021
Antibodies
Biosimilars and Diversification Drive Innovation in mAb Manufacturing
Bioprocessing
Biopharma Facility Planning Improves with Monte Carlo Simulation Modeling
Bioprocessing
Bioprocessing Gets a Jolt
Bioprocessing
Advanced Biotherapy Regulatory Considerations
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
A-Lists
Seven Biopharma Trends to Watch in 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Primers
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Home
Virology
HIV
HIV
Coronavirus
Dengue
Ebola
HBV
HCV
Herpes
HIV
HPV
Influenza
West Nile Virus
Zika
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
HIV
HIV Vaccine Clinical Trial Provides Promising Results
HIV
HIV Protein Trains Immune Cells to Be Hyper-Responsive, Resulting in Chronic Inflammation
HIV
HIV’s Vpu Protein Makes It Harder for Antibodies to Recognize Infected Cells
HIV
Study Suggests Patience is a Virtue When Vaccinating against HIV
HIV
Plant-Based Biologics Manufacturer Seeks to Boost U.K. Production
HIV
What’s Next for mRNA Vaccines?
HIV
Researchers Uncover How the Immune System Defends against HIV
HIV
Study Shows How Key HIV Protein Functions to Form Infectious Virus
HIV
Accelerated Aging Process at the DNA Level Seen after HIV Infection
HIV
Common HIV Treatment Improves Cognition in Down Syndrome Mice
HIV
Despite Low Monkeypox Risk, Vaccine Developers Prepare
HIV
Could a One-Shot Treatment for Patients with HIV Be on the...
HIV
Developing Non-Affinity Purification for HIV and SARS-CoV-2 Vaccines
HIV
ReiThera and Exothera Collaborate on Vaccine Manufacturing Process
HIV
DNA Vaccine for HIV Moves Forward with Tier-2 Neutralization in Mice
1
2
3
...
8
Page 1 of 8
Scroll Up
Login
Subscribe
![Sanction was based on study that found the HPV vaccine to be 78% effective.[alexfiodorov-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesDec2010Dec23_2010_10349430_GrayVirusHIV_GardasilApprovedForAnalCancer1148142105-324x160.jpg "DNA Vaccine for HIV Moves Forward with Tier-2 Neutralization in Mice")